1. Home
  2. BNTC vs RFI Comparison

BNTC vs RFI Comparison

Compare BNTC & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • RFI
  • Stock Information
  • Founded
  • BNTC 1995
  • RFI 1992
  • Country
  • BNTC United States
  • RFI United States
  • Employees
  • BNTC N/A
  • RFI N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • RFI Investment Managers
  • Sector
  • BNTC Health Care
  • RFI Finance
  • Exchange
  • BNTC Nasdaq
  • RFI Nasdaq
  • Market Cap
  • BNTC 339.8M
  • RFI 321.0M
  • IPO Year
  • BNTC N/A
  • RFI N/A
  • Fundamental
  • Price
  • BNTC $14.34
  • RFI $11.97
  • Analyst Decision
  • BNTC Strong Buy
  • RFI
  • Analyst Count
  • BNTC 7
  • RFI 0
  • Target Price
  • BNTC $24.43
  • RFI N/A
  • AVG Volume (30 Days)
  • BNTC 48.8K
  • RFI 69.8K
  • Earning Date
  • BNTC 05-12-2025
  • RFI 01-01-0001
  • Dividend Yield
  • BNTC N/A
  • RFI 8.25%
  • EPS Growth
  • BNTC N/A
  • RFI N/A
  • EPS
  • BNTC N/A
  • RFI N/A
  • Revenue
  • BNTC N/A
  • RFI N/A
  • Revenue This Year
  • BNTC N/A
  • RFI N/A
  • Revenue Next Year
  • BNTC N/A
  • RFI N/A
  • P/E Ratio
  • BNTC N/A
  • RFI N/A
  • Revenue Growth
  • BNTC N/A
  • RFI N/A
  • 52 Week Low
  • BNTC $4.75
  • RFI $9.62
  • 52 Week High
  • BNTC $16.90
  • RFI $12.52
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 55.36
  • RFI 47.76
  • Support Level
  • BNTC $14.90
  • RFI $11.90
  • Resistance Level
  • BNTC $16.90
  • RFI $12.04
  • Average True Range (ATR)
  • BNTC 1.15
  • RFI 0.17
  • MACD
  • BNTC 0.15
  • RFI -0.01
  • Stochastic Oscillator
  • BNTC 52.24
  • RFI 47.37

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

Share on Social Networks: